Chemically modified protein compositions and methods

Details for Australian Patent Application No. 2005229001 (hide)

Owner Amgen Inc.

Inventors Kinstler, Olaf B.; Gegg, Jr. Colin V.

Agent Shelston IP

Pub. Number AU-A-2005229001

PCT Pub. Number WO2005/094898

Priority 60/555,792 23.03.04 US

Filing date 23 March 2005

Wipo publication date 13 October 2005

International Classifications

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

Event Publications

26 October 2006 PCT application entered the National Phase

  PCT publication WO2005/094898 Priority application(s): WO2005/094898

10 September 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005229006-Use of loteprednol etabonate for the treatment of dry eye

2005228998-Gossypol co-crystals and the use thereof